Top
Synergistic effects of the combined treatment of U251 and T98G glioma cells with an anti-tubulin tetrahydrothieno[2,3-c]pyridine derivative and a peptide nucleic acid targeting miR-221-3p
International Journal of Oncology
Synergistic effects of the combined treatment of U251 and T98G glioma cells with an anti-tubulin tetrahydrothieno[2,3-c]pyridine derivative and a peptide nucleic acid targeting miR-221-3p
DOI: 10.3892/ijo.2021.5241, Volume: 59, Issue: 2, Pages: 0-0
Article Type: research-article,
Article History
received: 2021-2-28
accepted: 2021-6-10
published: 2021-7-6
Altmetric
Keywords
Apoptosis , Cell cycle , microRNA , glioma , Combination therapy , tubulin , miR-221 , anti-miR , peptide nucleic acid , tetrahydrothieno[2,3-c] pyridine
https://www.researchpad.co/tools/openurl?pubtype=&doi=10.3892/ijo.2021.5241&title=Synergistic effects of the combined treatment of U251 and T98G glioma cells with an anti-tubulin tetrahydrothieno[2,3-c]pyridine derivative and a peptide nucleic acid targeting miR-221-3p&author=&keyword=[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=305987}, {keywordId=805, uniqueName=cell-cycle, name=Cell cycle, contentId=305987}, {keywordId=1549, uniqueName=microrna, name=microRNA, contentId=305987}, {keywordId=2422, uniqueName=glioma, name=glioma, contentId=305987}, {keywordId=2633, uniqueName=combination-therapy, name=Combination therapy, contentId=305987}, {keywordId=14434, uniqueName=tubulin, name=tubulin, contentId=305987}, {keywordId=23760, uniqueName=mir-221, name=miR-221, contentId=305987}, {keywordId=98003, uniqueName=anti-mir, name=anti-miR, contentId=305987}, {keywordId=131094, uniqueName=peptide-nucleic-acid, name=peptide nucleic acid, contentId=305987}, {keywordId=368009, uniqueName=tetrahydrothieno[23-c]-pyridine, last=true, name=tetrahydrothieno[2,3-c] pyridine, contentId=305987}],[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=305987}, {keywordId=805, uniqueName=cell-cycle, name=Cell cycle, contentId=305987}, {keywordId=1549, uniqueName=microrna, name=microRNA, contentId=305987}, {keywordId=2422, uniqueName=glioma, name=glioma, contentId=305987}, {keywordId=2633, uniqueName=combination-therapy, name=Combination therapy, contentId=305987}, {keywordId=14434, uniqueName=tubulin, name=tubulin, contentId=305987}, {keywordId=23760, uniqueName=mir-221, name=miR-221, contentId=305987}, {keywordId=98003, uniqueName=anti-mir, name=anti-miR, contentId=305987}, {keywordId=131094, uniqueName=peptide-nucleic-acid, name=peptide nucleic acid, contentId=305987}, {keywordId=368009, uniqueName=tetrahydrothieno[23-c]-pyridine, last=true, name=tetrahydrothieno[2,3-c] pyridine, contentId=305987}],[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=305987}, {keywordId=805, uniqueName=cell-cycle, name=Cell cycle, contentId=305987}, {keywordId=1549, uniqueName=microrna, name=microRNA, contentId=305987}, {keywordId=2422, uniqueName=glioma, name=glioma, contentId=305987}, {keywordId=2633, uniqueName=combination-therapy, name=Combination therapy, contentId=305987}, {keywordId=14434, uniqueName=tubulin, name=tubulin, contentId=305987}, {keywordId=23760, uniqueName=mir-221, name=miR-221, contentId=305987}, {keywordId=98003, uniqueName=anti-mir, name=anti-miR, contentId=305987}, {keywordId=131094, uniqueName=peptide-nucleic-acid, name=peptide nucleic acid, contentId=305987}, {keywordId=368009, uniqueName=tetrahydrothieno[23-c]-pyridine, last=true, name=tetrahydrothieno[2,3-c] pyridine, contentId=305987}],[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=305987}, {keywordId=805, uniqueName=cell-cycle, name=Cell cycle, contentId=305987}, {keywordId=1549, uniqueName=microrna, name=microRNA, contentId=305987}, {keywordId=2422, uniqueName=glioma, name=glioma, contentId=305987}, {keywordId=2633, uniqueName=combination-therapy, name=Combination therapy, contentId=305987}, {keywordId=14434, uniqueName=tubulin, name=tubulin, contentId=305987}, {keywordId=23760, uniqueName=mir-221, name=miR-221, contentId=305987}, {keywordId=98003, uniqueName=anti-mir, name=anti-miR, contentId=305987}, {keywordId=131094, uniqueName=peptide-nucleic-acid, name=peptide nucleic acid, contentId=305987}, {keywordId=368009, uniqueName=tetrahydrothieno[23-c]-pyridine, last=true, name=tetrahydrothieno[2,3-c] pyridine, contentId=305987}],[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=305987}, {keywordId=805, uniqueName=cell-cycle, name=Cell cycle, contentId=305987}, {keywordId=1549, uniqueName=microrna, name=microRNA, contentId=305987}, {keywordId=2422, uniqueName=glioma, name=glioma, contentId=305987}, {keywordId=2633, uniqueName=combination-therapy, name=Combination therapy, contentId=305987}, {keywordId=14434, uniqueName=tubulin, name=tubulin, contentId=305987}, {keywordId=23760, uniqueName=mir-221, name=miR-221, contentId=305987}, {keywordId=98003, uniqueName=anti-mir, name=anti-miR, contentId=305987}, {keywordId=131094, uniqueName=peptide-nucleic-acid, name=peptide nucleic acid, contentId=305987}, {keywordId=368009, uniqueName=tetrahydrothieno[23-c]-pyridine, last=true, name=tetrahydrothieno[2,3-c] pyridine, contentId=305987}],[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=305987}, {keywordId=805, uniqueName=cell-cycle, name=Cell cycle, contentId=305987}, {keywordId=1549, uniqueName=microrna, name=microRNA, contentId=305987}, {keywordId=2422, uniqueName=glioma, name=glioma, contentId=305987}, {keywordId=2633, uniqueName=combination-therapy, name=Combination therapy, contentId=305987}, {keywordId=14434, uniqueName=tubulin, name=tubulin, contentId=305987}, {keywordId=23760, uniqueName=mir-221, name=miR-221, contentId=305987}, {keywordId=98003, uniqueName=anti-mir, name=anti-miR, contentId=305987}, {keywordId=131094, uniqueName=peptide-nucleic-acid, name=peptide nucleic acid, contentId=305987}, {keywordId=368009, uniqueName=tetrahydrothieno[23-c]-pyridine, last=true, name=tetrahydrothieno[2,3-c] pyridine, contentId=305987}],[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=305987}, {keywordId=805, uniqueName=cell-cycle, name=Cell cycle, contentId=305987}, {keywordId=1549, uniqueName=microrna, name=microRNA, contentId=305987}, {keywordId=2422, uniqueName=glioma, name=glioma, contentId=305987}, {keywordId=2633, uniqueName=combination-therapy, name=Combination therapy, contentId=305987}, {keywordId=14434, uniqueName=tubulin, name=tubulin, contentId=305987}, {keywordId=23760, uniqueName=mir-221, name=miR-221, contentId=305987}, {keywordId=98003, uniqueName=anti-mir, name=anti-miR, contentId=305987}, {keywordId=131094, uniqueName=peptide-nucleic-acid, name=peptide nucleic acid, contentId=305987}, {keywordId=368009, uniqueName=tetrahydrothieno[23-c]-pyridine, last=true, name=tetrahydrothieno[2,3-c] pyridine, contentId=305987}],[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=305987}, {keywordId=805, uniqueName=cell-cycle, name=Cell cycle, contentId=305987}, {keywordId=1549, uniqueName=microrna, name=microRNA, contentId=305987}, {keywordId=2422, uniqueName=glioma, name=glioma, contentId=305987}, {keywordId=2633, uniqueName=combination-therapy, name=Combination therapy, contentId=305987}, {keywordId=14434, uniqueName=tubulin, name=tubulin, contentId=305987}, {keywordId=23760, uniqueName=mir-221, name=miR-221, contentId=305987}, {keywordId=98003, uniqueName=anti-mir, name=anti-miR, contentId=305987}, {keywordId=131094, uniqueName=peptide-nucleic-acid, name=peptide nucleic acid, contentId=305987}, {keywordId=368009, uniqueName=tetrahydrothieno[23-c]-pyridine, last=true, name=tetrahydrothieno[2,3-c] pyridine, contentId=305987}],[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=305987}, {keywordId=805, uniqueName=cell-cycle, name=Cell cycle, contentId=305987}, {keywordId=1549, uniqueName=microrna, name=microRNA, contentId=305987}, {keywordId=2422, uniqueName=glioma, name=glioma, contentId=305987}, {keywordId=2633, uniqueName=combination-therapy, name=Combination therapy, contentId=305987}, {keywordId=14434, uniqueName=tubulin, name=tubulin, contentId=305987}, {keywordId=23760, uniqueName=mir-221, name=miR-221, contentId=305987}, {keywordId=98003, uniqueName=anti-mir, name=anti-miR, contentId=305987}, {keywordId=131094, uniqueName=peptide-nucleic-acid, name=peptide nucleic acid, contentId=305987}, {keywordId=368009, uniqueName=tetrahydrothieno[23-c]-pyridine, last=true, name=tetrahydrothieno[2,3-c] pyridine, contentId=305987}],[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=305987}, {keywordId=805, uniqueName=cell-cycle, name=Cell cycle, contentId=305987}, {keywordId=1549, uniqueName=microrna, name=microRNA, contentId=305987}, {keywordId=2422, uniqueName=glioma, name=glioma, contentId=305987}, {keywordId=2633, uniqueName=combination-therapy, name=Combination therapy, contentId=305987}, {keywordId=14434, uniqueName=tubulin, name=tubulin, contentId=305987}, {keywordId=23760, uniqueName=mir-221, name=miR-221, contentId=305987}, {keywordId=98003, uniqueName=anti-mir, name=anti-miR, contentId=305987}, {keywordId=131094, uniqueName=peptide-nucleic-acid, name=peptide nucleic acid, contentId=305987}, {keywordId=368009, uniqueName=tetrahydrothieno[23-c]-pyridine, last=true, name=tetrahydrothieno[2,3-c] pyridine, contentId=305987}],&subject=
Get the app for your Mobile or Tablet!
© 2024 Newgen KnowledgeWorks |
Privacy & Cookie Policy | Powered by: Nova